Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Montelukast API Companies

Several pharmaceutical companies were known to be involved in the production and distribution of Montelukast Active Pharmaceutical Ingredient (API), which is used in the manufacturing of medications for the treatment of asthma and seasonal allergies.

Latest Montelukast Active Pharmaceutical Ingredient Companies Update

May 2023: Montelukast active pharmaceutical ingredient market leader Sandoz has announced a €25 million investment in its Holzkirchen, Germany, manufacturing facility to increase its biosimilar research capacities. By the fourth quarter of 2023, the business plans to have expanded its Biopharma Technical Development (BioTD) capabilities and converted the lab building into a cutting-edge biotech facility. The funding will be used to consolidate state-of-the-art labs and analytical resources into one convenient location. The funding "further solidifies Bavaria's standing as a prominent biotechnology powerhouse. Up to 45 full-time employees are likely to join the site as a result of capacity development and engagement with universities in Munich and research organizations, as stated by Sandoz.

July 2023: An estimated USD 90 million was disclosed by Sandoz, a world leader in generic and biosimilar pharmaceuticals including the Montelukast API. This investment would position Sandoz's Ljubljana facility as a significant hub for the company's research and development of biosimilar products. About two hundred new permanent employment will be created as a result of the relocation, and the company's capacity for developing biosimilars from start to finish will be bolstered by the move. It also expands upon Sandoz's proven complete capabilities in Ljubljana for developing technologically challenging generic medications, particularly small molecule products.

May 2023: Sandoz, Novartis's generics subsidiary and a leader in off-patent generic and biosimilar drugs like Montelukast API, agreed to a multi-year strategic partnership with Just -Evotec Biologics, the Seattle, Washington, US subsidiary of Germany's Evotec, in May 2023. The deal includes the potential for the development and production of more biosimilars. It's the latest development in Sandoz's efforts to become an independent provider of off-patent pharmaceuticals.

List of Montelukast Active Pharmaceutical Ingredient Key companies in the market

Sandoz International GmbH (Germany)

Teva Pharmaceutical Industries Ltd (Israel)

Dr. Reddys Laboratories Ltd (India)

Morepen Laboratories Ltd (India)

Mylan N.V. (US)

Teva Pharmaceutical Industries Ltd (Israel)

Vintage Pharmaceuticals Inc (US)

Hikma Pharmaceuticals PLC (UK)

Glenmark (India)

Merck Sharp and Dohme Corp (US)

Sandoz International GmbH (Germany)

Hetero (India)

Aurobindo Pharma (India)

Montelukast API Market Highlights:

Montelukast API Market Size

Montelukast API Market Trends

Montelukast API Market Analysis

Montelukast API Market Share

Montelukast API Market Highlights:

Montelukast API Market Trends

Montelukast API Market Analysis

Montelukast API Market Share

Montelukast API Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.